Kindred Biosciences, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 2.395 million compared to USD 603,000 a year ago. Operating loss was USD 9.166 million compared to USD 22.390 million a year ago. Net loss was USD 9.740 million compared to USD 22.761 million a year ago. Basic loss per share from continuing operations was USD 0.24 compared to USD 0.58 a year ago.